Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Different people with severe hair loss respond to baricitinib treatment at different times, with some showing improvement early, some gradually, and others later.

A man with severe hair loss and skin disease regrew his hair with no side effects after taking tofacitinib.

Compound 4 is a promising treatment for hair loss with low toxicity.

Upadacitinib and narrowband UVB effectively treated a child's vitiligo and alopecia areata.

Tofacitinib effectively treated a woman's severe symptoms from a rare autoimmune condition.

Jujube fruit extract may reduce kidney damage from ibuprofen in rats.

Beta-blockers can cause rare skin side-effects, which usually improve after stopping the medication.

The choice between belimumab and anifrolumab depends on the specific symptoms of the patient's lupus.

Valproic acid may cause hair loss by reducing biotinidase enzyme activity in rats.

CI-1033 causes skin lesions in rats, similar to humans, due to EGF receptor inhibition.

Long-term use of Risperidone may be linked to a serious skin condition in bipolar patients, affecting their overall well-being.

Using an anti-ICAM-1 antibody with rapamycin improves hair transplant survival in monkeys.

Baricitinib is effective and safe for treating severe alopecia areata.

Tapering and stopping tofacitinib may be possible for young alopecia areata patients.

JAK inhibitors, like baricitinib, are effective and safe for treating alopecia areata.

JAK inhibitors may effectively treat lichen planopilaris and frontal fibrosing alopecia with minimal side effects.

Tofacitinib effectively reduced hair loss in alopecia areata patients without adverse effects.

Ritlecitinib is safe and may effectively treat alopecia areata.

Baricitinib is a safe and effective treatment for severe alopecia areata.

Centipeda minima and brevilin A protect skin cells from damage and aging.

Comprehensive screening for infections is crucial before starting JAK inhibitors in alopecia areata patients.

Tofacitinib effectively treated severe hair loss in a patient who didn't respond to other treatments.

Ruxolitinib can cause a delayed skin reaction on the nose.

Baricitinib effectively improved both atopic dermatitis and alopecia areata symptoms in a patient.

Tofacitinib temporarily regrew hair in a man with alopecia, but its effects didn't last.

Tofacitinib helped regrow hair in a woman with alopecia areata.

Tofacitinib effectively treated both alopecia areata and Crohn's disease in a 12-year-old.